Aerie appoints Raj Kannan as CEO
Click Here to Manage Email Alerts
Raj Kannan has been appointed as CEO of Aerie Pharmaceuticals, effective Dec. 20, according to a company press release.
“Raj brings a track record of building effective organizations and teams, launching and growing products in the U.S. and globally, building commercial operations, providing strategic direction to pipeline development and successfully guiding companies through important inflections in their growth trajectories,” Benjamin F. McGraw III, PharmD, executive chairman of the board of directors, said in the release.
Most recently, Kannan was CEO and president of Chiasma. He previously served as chief commercial officer of Kiniksa Pharmaceuticals and held positions at Merck and Boehringer Ingelheim.
“The Aerie team has built an impressive ophthalmology company with an exciting glaucoma franchise that is global in reach and an exciting pipeline of product development candidates that has the potential to create significant value,” Kannan said in the release. “I am honored to have this opportunity to lead the company and work with this team to deliver on our commercial prospects and realize the full promise of our pipeline.”
Read more about
Click Here to Manage Email Alerts